Watson Wants Lidoderm, Opana Pay-For-Delay Suits Split
Watson Laboratories Inc. and its owner Allergan PLC on Thursday asked a Pennsylvania federal court to sever the Federal Trade Commission's case claiming that it delayed generic competition for Lidoderm from...To view the full article, register now.
Already a subscriber? Click here to view full article